Ro 5185426 US11332479, Compound Vemurafenib US10570155, Vemurafenib US11492357, Control PLX-4032 US9388165, Reference, Vemurafenib (PLX-4032) RG 7204 BDBM50396483 USRE47451, PLX-4032, Roche VEMURAFENIB
- Barresi, E; Baldanzi, C; Roncetti, M; Roggia, M; Baglini, E; Lepori, I; Vitiello, M; Salerno, S; Tedeschi, L; Da Settimo, F; Cosconati, S; Poliseno, L; Taliani, S A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAF Eur J Med Chem 256: (2023)
- Juchum, M; Pfaffenrot, B; Klövekorn, P; Selig, R; Albrecht, W; Zender, L; Laufer, SA Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors. Eur J Med Chem 240: (2022)
- Cheng, H; Chang, Y; Zhang, L; Luo, J; Tu, Z; Lu, X; Zhang, Q; Lu, J; Ren, X; Ding, K Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib. J Med Chem 57: 2692-703 (2014)